Mutant of Moloney murine leukemia virus reverse transcriptase exhibits higher resistance to common RT-qPCR inhibitors

Analytical Biochemistry

Volumn 400, Issue 2, 2010, Pages 301-303

  Arezi, Bahram ^a   McCarthy, Melissa ^a   Hogrefe, Holly ^a  

^a AGILENT TECHNOLOGIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMIDES; DISEASES; ENZYMES; ETHYLENEDIAMINETETRAACETIC ACID; POLYMERASE CHAIN REACTION;

ACIDIC POLYSACCHARIDES; CELL LYSATES; FORMAMIDES; MURINE LEUKEMIA VIRUS; QUANTITATIVE POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASES; REVERSE TRANSCRIPTION; WILD TYPES;

VIRUSES;

RNA DIRECTED DNA POLYMERASE;

ARTICLE; BINDING AFFINITY; DENATURATION; DNA DETERMINATION; DNA SYNTHESIS; GENE MUTATION; HEAT TOLERANCE; IC 50; MOLONEY LEUKEMIA ONCOVIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS;

MOLONEY MURINE LEUKEMIA VIRUS;

EID: 77950691395     PISSN: 00032697     EISSN: 10960309     Source Type: Journal    
DOI: 10.1016/j.ab.2010.01.024     Document Type: Article

References (13)

1. Arezi B., Salehi M. High quality external RNA control detects inhibitors in RNA samples. Strategies (Stratagene newsletter) 2006, 19:52.
2. Nolan T., Hands R.E., Ogunkolade W., Bustin S.A. SPUD: A quantitative PCR assay for the detection of inhibitors in nucleic acid preparations. Anal. Biochem. 2006, 351:308-310.
3. Smith R.D., Brown B., Ikonomi P., Schechtern A.N. Exogenous reference RNA for normalization of real-time quantitative PCR. BioTechniques 2003, 34:88-91.
4. Hugget J.F., Novak T., Garson J.A., Green C., Morris-Jones S.D., Miller R.F., Zumla A. Differential susceptibility of PCR reactions to inhibitors: an important and unrecognized phenomenon. BMC Res. Notes 2008, 1:70.
5. Gerard G.F., Fox D.K., Nathan M., D'Alessio J.M. Reverse transcriptase: the use of cloned Moloney murine leukemia virus reverse transcriptase to synthesize DNA from RNA. Mol. Biotechnol. 1997, 8:61-77.
6. Arezi B., Hogrefe H. Novel mutations in Moloney murine leukemia virus reverse transcriptase increase thermostability through tighter binding to template-primer. Nucleic Acids Res. 2009, 37:473-481.
7. Gerard G.F., Potter R.J., Smith M.D., Rosenthal K., Dhariwal G., Lee J., Chatterjee D.K. The role of template-primer in protection of reverse transcriptase from thermal inactivation. Nucleic Acids Res. 2002, 30:3118-3129.
8. M.D. Smith, R.J. Potter, G. Dhariwal, G.F. Gerard, K. Rosenthal, J.E. Lee, Thermostable reverse transcriptases and uses thereof, US patent application 20070141592 (2007).
9. Potter J., Zheng W., Lee J. Thermal stability and cDNA synthesis capability of SuperScript III reverse transcriptase. Focus (Invitrogen newsletter) 2003, 25(1):19-24.
10. Chandler D.P., Wagnon C.A., Bolton H. Reverse transcriptase (RT) inhibition of PCR at low concentrations of template and its implications for quantitative RT-PCR. Appl. Environ. Microbiol. 1998, 64:669-677.
11. Suslov O., Steindler D.A. PCR inhibition by reverse transcriptase leads to an overestimation of amplification efficiency. Nucleic Acids Res. 2005, 33:e181.
12. Ghadessy F.J., Ong J.L., Holliger P. Directed evolution of polymerase function by compartmentalized self-replication. Proc. Natl. Acad. Sci. USA 2001, 98:4552-4557.
13. Kermekchiev M.B., Kirilova L.I., Vail E.E., Barnes W.M. Mutants of Taq DNA polymerase resistant to PCR inhibitors allow DNA amplification from whole blood and crude soil samples. Nucleic Acids Res. 2009, 37:e40.